KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation

Paolo Lazzari, Marco Spiga, Monica Sani, Matteo Zanda, Ian N Fleming

Research output: Contribution to journalArticlepeer-review

9 Downloads (Pure)

Fingerprint

Dive into the research topics of 'KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation'. Together they form a unique fingerprint.

Chemical Compounds